Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.15
Bid: 8.80
Ask: 9.50
Change: 0.00 (0.00%)
Spread: 0.70 (7.955%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 9.15
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK DIRECTOR DEALINGS SUMMARY: Citrus Buys More easyHotel At Exit Price

Tue, 28th Apr 2020 14:43

(Alliance News) - The follow is a round-up of share dealings by London-listed company directors and managers announced on Monday and Tuesday and not separately reported by Alliance News:

----------

easyHotel PLC - Citrus Holdco Ltd, the investment vehicle of Chair Hermanus Meijer, Non-Executive Director Charles Persello, and Michael Neuman, representative of corporate director Cadim Fonds Inc, buys 183,688 shares at GBP0.70, worth GBP128,582, on Friday last week. At the start of last week, easyHotel offered an exit opportunity to minority shareholders at the same price. Citrus Holdco held 71.2% of the shares at that point, with brand-owner easyGroup having 25.8%, leaving just 3% in public hands. easyHotel plans to cancel its listing on AIM from May 19.

----------

Witan Investment Trust PLC - Non-Executive Director Gabrielle Boyle buys 28,683 shares at 173.41p, worth GBP49,739, on Monday.

----------

Scancell Holdings PLC - Non-Executive Director Martin Diggle sells 2.0 million shares via Vulpes Life Science Fund, at 8p, worth GBP160,000, on Monday and Friday last week. Vulpes now holds 78.5 million shares, a 17% stake.

----------

Manchester & London Investment Trust PLC - Investment Manager Mark Sheppard sells 58,266 shares at GBP5.62 and GBP5.66, worth GBP327,586, on Monday.

----------

Geiger Counter Ltd - Chair George Baird buys 100,000 shares at GBP0.17, worth GBP16,680, on Friday last week.

----------

Alfa Financial Software Holdings PLC - Chief Financial Officer Duncan Magrath buys 100,000 shares at GBP0.79, worth GBP79,000, on Monday.

----------

Artemis Alpha Trust PLC - Fund Manager Kartik Kumar buys 12,500 shares at GBP2.45, worth GBP30,625, on Friday last week.

----------

Jadestone Energy Inc - Non-Executive Chair Dennis McShane buys 150,732 shares at 43.02p to 44.40p, worth GBP65,337, on Friday last week and Monday. Now holds 453,651 shares.

----------

Salt Lake Potash Ltd - Chair Ian Middlemas buys 2.3 million shares, CEO Tony Swiericzuk 505,883, and CFO Shaun Day 102,941 last week, as part of company's placement of 58.8 million shares at AUD0.34 to raise AUD20.0 million. The funds will be used to deliver the Lake Way project in Western Australia. Salt Lake Potash said commissioning is expected to commence in December with first production in the first quarter of 2021.

----------

City Merchants High Yield Trust Ltd - Non-executive directors Tim Scholefield and Stuart McMaster buy 6,000 shares at 171.80p and 25,000 shares at 171.67p, respectively, on Tuesday. The purchases are together worth GBP53,000.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
20 Nov 2019 10:01

Scancell To Receive New European Patent For Moditope Product

Scancell To Receive New European Patent For Moditope Product

Read more
23 Oct 2019 10:48

Scancell Hires Former Genkyotex Boss Ursula Ney As Non-Executive

Scancell Hires Former Genkyotex Boss Ursula Ney As Non-Executive

Read more
5 Sep 2019 16:03

UK Shareholder Meetings Calendar - Next 7 Days

Friday 6 SeptemberMySale Group (re share placing)Berkeley GroupGreene 9 African Oil & 10 11 Design

Read more
4 Sep 2019 08:58

Scancell signs collaboration agreement with antibody technology company

(Sharecast News) - Cancer treatment developer Scancell has inked its first collaboration agreement with a "leading" antibody technology company for its new platform technology, AvidiMab.

Read more
20 Aug 2019 10:59

Scancell losses deepen as it presses on with development

(Sharecast News) - Novel immunotherapies developer Scancell Holdings reported a deeper operating loss in its final results on Tuesday, to £6.73m compared to £4.91m in the 2018 financial year.

Read more
20 Aug 2019 10:59

Scancell Annual Loss Widens Amid Product Pipeline Development

(Alliance News) - Immunotherapy firm Scancell Holdings PLC on Tuesday said its loss widened on higher development costs, while it is making strong progress on advancing its the 12 months to the of

Read more
19 Aug 2019 09:33

Scancell to begin SCIB1 UK trial as FDA issues linger in US

(Sharecast News) - Immunotherapy developer Scancell announced the initiation of and further updates to the 'SCIB1' phase 2 trial in patients with metastatic melanoma also receiving the checkpoint inhibitor 'pembrolizumab' (Keytruda) on Monday.

Read more
13 Aug 2019 15:58

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 14 AugustĀ AvastHalf Year ResultsLookersHalf Year BeattyHalf Year Year

Read more
1 Jul 2019 14:42

Scancell Progresses Trials In "Busy And Productive" Six Months

(Alliance News) - Scancell Holdings PLC said on Monday it has been a "busy and productive" six months for the company.The company said that active patient recruitment for the two

Read more
18 Jun 2019 14:40

Scancell Appoints Vulpes Investment Management Co-Founder To Board

(Alliance News) - Scancell Holdings PLC on Tuesday said it has appointed Vulpes Investment Management Co-Founder & Portfolio Manager Martin Diggle to its board.Diggle joins the cancer a

Read more
13 Jun 2019 13:48

Scancell Shares Jump 30% As Vulpes Invests GBP4 Million (ALLISS)

(Alliance News) - Scancell Holdings PLC's shares soared Thursday as it received GBP3.9 million from a new investor.Scancell shares were up 31% in afternoon trade at a price of 7.00 Life

Read more
21 May 2019 13:25

N4 Pharma Appoints John Chiplin as Non-Executive Chairman

LONDON (Alliance News) - N4 Pharma PLC on Tuesday said it appointed John Chiplin as non-executive chair of the company with immediate effect.Furthermore, the pharmaceutical firm appointed a

Read more
20 May 2019 11:03

Scancell partnership with Cancer Research moves closer to clinic

(Sharecast News) - Immunotherapy developer Scancell Holdings updated the market on its clinical development partnership with Cancer Research UK for the development of the ;ImmunoBody' vaccine, SCIB2, as a potential treatment for patients with solid tumours, including non-small cell lung cancer (NSCLC), on Monday.

Read more
20 May 2019 11:02

Scancell Says Cancer Vaccine SCIB2 Will Be Given Using New Formulation

LONDON (Alliance News) - Scancell Holdings PLC said Monday cancer vaccine SCIB2 is to be administered using a new nanoparticle formulation in an early stage trial.Shares in Scancell were up

Read more
10 May 2019 10:49

Scancell Creates Advisory Board And Prepares For Drug Trials

LONDON (Alliance News) - Scancell Holdings PLC on Friday said it has established a clinical advisory board and has begun manufacturing and toxicity testing on its tumour drug in immunotherapy were

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.